Purpose Although there is evidence supporting the benefits of corticosteroids in patients
affected with severe coronavirus disease 2019 (COVID-19), there is little information related …

Objective To determine if the use of corticosteroids was associated with Intensive Care Unit
(ICU) mortality among whole population and pre-specified clinical phenotypes. Design A …

Background Some unanswered questions persist regarding the effectiveness of
corticosteroids for severe coronavirus disease 2019 (COVID-19) patients. We aimed to …

Background Corticosteroids are a potential therapeutic agent for patients with COVID-19
pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data …

Introduction While guidelines stronglyrecommend dexamethasone in critical COVID-19, the
optimal threshold to initiate corticosteroids in non-critically ill patients with COVID-19 …

Background In the current SARS-CoV-2 pandemic, there has been worldwide debate on the
use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of …

The most beneficial effect of corticosteroid therapy in COVID‐19 patients has been shown in
subjects receiving invasive mechanical ventilation (IMV), corresponding to a score of 6 on …

Corticosteroids use in coronavirus disease 2019 (COVID-19) is controversial, especially in
mild to severe patients who do not require invasive/noninvasive ventilation. Moreover, many …

Objective To assess the efficacy of corticosteroids in patients with coronavirus disease 2019
(COVID-19). Methods A multicentre observational study was performed from 22 February …

Objectives Efficacy and safety of corticosteroids in patients with 2019-nCoV (novel
coronavirus 2019) infection still are debated. Because large randomized clinical trials …